Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chimerix

8.54
+0.0000
Volume:- -
Turnover:- -
Market Cap:801.08M
PE:-8.63
High:8.54
Open:8.54
Low:8.54
Close:8.54
Loading ...

Wedbush Downgrades Chimerix to Neutral From Outperform, Adjusts Price Target to $8.55 From $7

MT Newswires Live
·
05 Mar

Jazz's Chimerix Deal Could Bring Valuable FDA Voucher -- Market Talk

Dow Jones
·
05 Mar

Investors Look for Signs of Tariff Easing as US Futures Rise Modestly Pre-Bell

MT Newswires Live
·
05 Mar

Chimerix Inc : Wedbush Cuts to Neutral From Outperform; Raises Target Price to $8.55 From $7

THOMSON REUTERS
·
05 Mar

BRIEF-Jazz Pharmaceuticals Upon Termination Of Deal Chimerix Will Be Required To Pay Termination Fee Of $35 Million In Cash

Reuters
·
05 Mar

BRIEF-Jazz Pharmaceuticals To Acquire Chimerix

Reuters
·
05 Mar

BUZZ-Chimerix surges on Jazz Pharma's $935 million buyout

Reuters
·
05 Mar

Chimerix Shares Jump 69.8% to $8.4 Premarket After Jazz Pharmaceuticals to Buy Co for $935 Million

THOMSON REUTERS
·
05 Mar

Chimerix Merges with Jazz Pharmaceuticals in $935M Deal

TIPRANKS
·
05 Mar

Jazz Pharmaceuticals to Acquire Chimerix in $935M Deal

TIPRANKS
·
05 Mar

Jazz Pharmaceuticals to Acquire Chimerix in $935 Million Deal

MT Newswires Live
·
05 Mar

Jazz Pharmaceuticals:Upon Termination of Deal Under Specified Circumstances, Chimerix Will Be Required to Pay Co Termination Fee of $35 Mln in Cash

THOMSON REUTERS
·
05 Mar

Jazz Pharmaceuticals to buy Chimerix for $935 million

Reuters
·
05 Mar

Jazz Pharmaceuticals to Buy Chimerix for Roughly $935 Million

MT Newswires Live
·
05 Mar

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

THOMSON REUTERS
·
05 Mar

Chimerix Inc - Jazz to Fund Transaction Through Existing Cash and Investments

THOMSON REUTERS
·
05 Mar

Chimerix Inc - Deal Valued at $935 Million, or $8.55 per Share

THOMSON REUTERS
·
05 Mar

Chimerix Inc - Transaction Valued at $8.55 per Share

THOMSON REUTERS
·
05 Mar

Chimerix Inc - Transaction Valued at $935 Million, or $8.55 per Share

THOMSON REUTERS
·
05 Mar

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

PR Newswire
·
05 Mar